15-17 April, 2019

The Waldorf Hilton

London, UK

9004 Website - Full Event Brochure Header9004 World CDx 270x60 Download Brochure Button

The Clinical Biomarkers & World CDx Europe Summit 2018 was focused on improving the development and clinical validation of biomarker signatures to better demonstrate efficacy for targeted therapeutics and accelerate the commercialisation of Dx-enabled precision medicines.

Download the 2018 event guide to take a peak at last years’ speaker faculty and agenda content abstracts, as well as a breakdown of attending companies, audience demographics and registration discounts.

Key Topics Addressed in 2018:

symbol logo Understand the impact of the European IVDR on targeted therapeutic development, drug-Dx launch and real-world adoption and uptake of precision medicines
 symbol logo  Improve the success of biomarker driven clinical trials through innovation in biomarker sampling, trial design  and clinical evidence reporting
 symbol logo Evolve your European market access strategy to ensure successful commercialization, adoption and acquisition of market share for your drug-Dx product
symbol logo Learn how to apply the hottest novel predictive signatures from TMB to ctDNA, to improve the accuracy of patient selection
 symbol logo Refine your drug and Dx reimbursement strategy, gaining clarity on the payer perspective and the harnessing of RWE and health economics, to accelerate uptake of your precision medicine

9004 World CDx 270x60 Download Brochure Button